Cargando…

A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement

BACKGROUND: In high-throughput demanding fields, such as biotechnology and structural biology, molecular cloning is an essential tool in obtaining high yields of recombinant protein. Here, we address recently developed restriction-free methods in cloning, and present a more cost-efficient protocol t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lund, Bjarte Aarmo, Leiros, Hanna-Kirsti Schrøder, Bjerga, Gro Elin Kjæreng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996003/
https://www.ncbi.nlm.nih.gov/pubmed/24612508
http://dx.doi.org/10.1186/1475-2859-13-38
_version_ 1782312970081009664
author Lund, Bjarte Aarmo
Leiros, Hanna-Kirsti Schrøder
Bjerga, Gro Elin Kjæreng
author_facet Lund, Bjarte Aarmo
Leiros, Hanna-Kirsti Schrøder
Bjerga, Gro Elin Kjæreng
author_sort Lund, Bjarte Aarmo
collection PubMed
description BACKGROUND: In high-throughput demanding fields, such as biotechnology and structural biology, molecular cloning is an essential tool in obtaining high yields of recombinant protein. Here, we address recently developed restriction-free methods in cloning, and present a more cost-efficient protocol that has been optimized to improve both cloning and clone screening. RESULTS: In our case study, three homologous β-lactamase genes were successfully cloned using these restriction-free protocols. To clone the genes, we chose a gene replacement strategy, where the recombinant genes contained overhangs that targeted a region of the expression vector including a cytotoxin-encoding ccdB-gene. CONCLUSION: We provide further evidence that gene replacement can be applied with high-throughput cloning protocols. Targeting a replacement of the ccdB-gene was found to be very successful for counterselection using these protocols. This eliminated the need for treatment with the restriction enzyme DpnI that has so far been the preferred clone selection approach. We thus present an optimized cloning protocol using a restriction-free ccdB-gene replacement strategy, which allows for parallel cloning at a high-throughput level.
format Online
Article
Text
id pubmed-3996003
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39960032014-04-24 A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement Lund, Bjarte Aarmo Leiros, Hanna-Kirsti Schrøder Bjerga, Gro Elin Kjæreng Microb Cell Fact Technical Notes BACKGROUND: In high-throughput demanding fields, such as biotechnology and structural biology, molecular cloning is an essential tool in obtaining high yields of recombinant protein. Here, we address recently developed restriction-free methods in cloning, and present a more cost-efficient protocol that has been optimized to improve both cloning and clone screening. RESULTS: In our case study, three homologous β-lactamase genes were successfully cloned using these restriction-free protocols. To clone the genes, we chose a gene replacement strategy, where the recombinant genes contained overhangs that targeted a region of the expression vector including a cytotoxin-encoding ccdB-gene. CONCLUSION: We provide further evidence that gene replacement can be applied with high-throughput cloning protocols. Targeting a replacement of the ccdB-gene was found to be very successful for counterselection using these protocols. This eliminated the need for treatment with the restriction enzyme DpnI that has so far been the preferred clone selection approach. We thus present an optimized cloning protocol using a restriction-free ccdB-gene replacement strategy, which allows for parallel cloning at a high-throughput level. BioMed Central 2014-03-10 /pmc/articles/PMC3996003/ /pubmed/24612508 http://dx.doi.org/10.1186/1475-2859-13-38 Text en Copyright © 2014 Lund et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Technical Notes
Lund, Bjarte Aarmo
Leiros, Hanna-Kirsti Schrøder
Bjerga, Gro Elin Kjæreng
A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement
title A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement
title_full A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement
title_fullStr A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement
title_full_unstemmed A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement
title_short A high-throughput, restriction-free cloning and screening strategy based on ccdB-gene replacement
title_sort high-throughput, restriction-free cloning and screening strategy based on ccdb-gene replacement
topic Technical Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996003/
https://www.ncbi.nlm.nih.gov/pubmed/24612508
http://dx.doi.org/10.1186/1475-2859-13-38
work_keys_str_mv AT lundbjarteaarmo ahighthroughputrestrictionfreecloningandscreeningstrategybasedonccdbgenereplacement
AT leiroshannakirstischrøder ahighthroughputrestrictionfreecloningandscreeningstrategybasedonccdbgenereplacement
AT bjergagroelinkjæreng ahighthroughputrestrictionfreecloningandscreeningstrategybasedonccdbgenereplacement
AT lundbjarteaarmo highthroughputrestrictionfreecloningandscreeningstrategybasedonccdbgenereplacement
AT leiroshannakirstischrøder highthroughputrestrictionfreecloningandscreeningstrategybasedonccdbgenereplacement
AT bjergagroelinkjæreng highthroughputrestrictionfreecloningandscreeningstrategybasedonccdbgenereplacement